Brain cancers are some of the hardest to treat. The five-year survival rate for patients with glioblastoma is only about 5% after diagnosis. Tackling this and other deadly brain cancers isn’t a one-person job; collaboration is key. What better place to get those conversations going than Cold Spring Harbor Laboratory (CSHL)? For more than a... The post CSHL launches inaugural brain tumor meeting appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Neurofibromatosis type 1 (NF1) is a rare genetic condition that affects approximately 100,000 Americans. Children diagnosed with the disorder often have motor delays and learning disabilities. Many are also diagnosed with autism or brain tumors. While significant progress has been made in understanding the biology of NF1 in animal models, translating these findings into clinical... The post NF1: Scientific insight and systemic change appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Tens of millions of people affected by brain cancer, strokes, Alzheimer’s, Parkinson’s, and other neurological diseases share a painful dilemma: a lack of viable therapeutic options. Tantalizingly, one of the biggest treatment obstacles is the very thing that protects the brain from harm: the blood-brain barrier (BBB). While the BBB does a remarkable job of... The post ‘The bridge between hope and healing’ appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
In sixth grade science class, we were sitting at our assigned tables watching a video about Galápagos tortoises. Or we were supposed to be anyway. Brad and I were playing football with one of those origami footballs. I don’t know which one of us folded it anymore, but we were giggling and having fun and […]| Emily Suess
Precision Without the Pressure: Smarter Brain Tumor Monitoring In the management of brain tumors, precision is everything. From initial diagnosis […] The post Precision Without the Pressure: Smarter Brain Tumor Monitoring appeared first on Cortechs.ai.| Cortechs.ai
San Diego, CA – Cortechs.ai, a pioneer in AI-powered medical imaging solutions, is pleased to announce the immediate availability of its […] The post Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation appeared first on Cortechs.ai.| Cortechs.ai
Pioneering research ‘fundamentally changed’ our understanding of brain cancer and opened the door to new treatments.| UVA Health Newsroom
Sometimes I chastise myself for overthinking things, especially when it comes to anxious thoughts. However, I’ve realized that no one else is going to analyze this stuff for me. I do self-guided therapy because of the expense (financial and otherwise) of traditional therapy. So thinking about things deeply is to dwell in the belly of […]| Emily Suess
I didn't have the best week. Of four appointments, I had to cancel four. An MRI, a CT, dentist appointment, and primary doctor appointment.| Emily Suess
Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG| ECOG-ACRIN Advocacy Blog
Yes, that's a Napoleon Dynamite reference. Yes, I'm one of like three people on the planet who thinks that movie is hilarious.| Emily Suess
Monday's dentist visit to get a temporary crown was hard on me. I'm just now getting around to writing about it, though.| Emily Suess
Researchers at Harvard Medical School have developed a new AI-powered tool to help brain surgeons combat cancer. CHARM rapidly evaluates tumorous tissue during surgery to help professionals make on-the-spot decisions about how to proceed.| New Atlas
They are also more likely to fail standardized tests and to need accommodations.| news.ufl.edu
Unwinding Anxiety in practice is something I have to do when the opportunity presents itself. There's no cramming for this life test.| Emily Suess
📄4mins. A 22-year-old male with diffuse midline glioma began taking 444 mg of Fenbendazole daily after standard treatments failed. Within months, MRI scans showed significant tumor reduction, highlighting Fenbendazole's potential as an alternative brain cancer treatment.| Fenbendazole resource
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.| cancer.ufl.edu